Seamus Cotter (@cotterseamus) 's Twitter Profile
Seamus Cotter

@cotterseamus

Stage IV Lung cancer survivor! Runs for fun, gardener, Addisons Disease, Chairperson of the Irish Lung Cancer Community (ILCC) (Facebook, Instagram & Twitter)

ID: 1226619610222538752

calendar_today09-02-2020 21:31:35

3,3K Tweet

740 Takipçi

880 Takip Edilen

Jill Feldman (@jillfeldman4) 's Twitter Profile Photo

For context, I made this slide for a talk I gave on PROs - patients r the only reliable source of data on QOL, severity of sympt/AEs & impact on daily life. Grade 1 can impact, esp when persistent & managing them is a $$ tox! Tolerable is @ being able to function, to LIVE. #LCSM

For context, I made this slide for a talk I gave on PROs - patients r the only reliable source of data on QOL, severity of sympt/AEs & impact on daily life. Grade 1 can impact, esp when persistent & managing them is a $$ tox! Tolerable is @ being able to function, to LIVE. #LCSM
Dr Anne-Marie Baird (@bairdam) 's Twitter Profile Photo

Financial toxicity is a reality for many families impacted by lung cancer as shown by our Lung Cancer Europe report as well as the other two presentations in this morning's session #WCLC24 GO2 for Lung Cancer LUNGevity Foundation #WCLC24

Financial toxicity is a reality for many families impacted by lung cancer as shown by our <a href="/LungCancerEu/">Lung Cancer Europe</a> report as well as the other two presentations in this morning's session #WCLC24 <a href="/GO2forLungCancr/">GO2 for Lung Cancer</a>
<a href="/LUNGevity/">LUNGevity Foundation</a> 
#WCLC24
Jarushka Naidoo (@drjnaidoo) 's Twitter Profile Photo

#WCLC24 Immunotherapy mini-orals Pleased to present an analysis of the use of proteomic signatures to identify immune-related toxicities including specific irAEs in patients with NSCLC, & to differentiate these from those from chemotherapy IASLC OncoHost Beaumont RCSI Cancer Centre 1/1

#WCLC24 Immunotherapy mini-orals

Pleased to present an analysis of the use of proteomic signatures to identify immune-related toxicities including specific irAEs in patients with NSCLC, &amp; to differentiate these from those from chemotherapy

<a href="/IASLC/">IASLC</a> <a href="/OncoHost/">OncoHost</a> <a href="/CancerCentreIre/">Beaumont RCSI Cancer Centre</a> 1/1
Lung Cancer Europe (@lungcancereu) 's Twitter Profile Photo

LUCE President Dr Dr Anne-Marie Baird, a Senior Research Fellow at Trinity College Dublin, gave a really insightful and well-received presentation on the final day of the World Conference on Lung Cancer in San Diego. #WCLC24 1/3

LUCE President Dr <a href="/BairdAM/">Dr Anne-Marie Baird</a>, a Senior Research Fellow at <a href="/tcddublin/">Trinity College Dublin</a>, gave a really insightful and well-received presentation on the final day of the World Conference on Lung Cancer in San Diego.
#WCLC24
1/3
Gerry Hanna (@gerryhanna) 's Twitter Profile Photo

So delighted to present our wonderful #RadOnc Lung Cancer Nurse Fiona Liston at SLRON St James's Hospital with a white ribbon from The White Ribbon Project™ sent by Drew Moghanaki 🐕 from #WCLC24 Fiona thanks for all the fabulous work you do for patients with lung cancer🤍🫁 #thewhiteribbonproject

So delighted to present our wonderful #RadOnc Lung Cancer Nurse Fiona Liston at SLRON <a href="/stjamesdublin/">St James's Hospital</a> with a white ribbon from <a href="/TheWRP4LC/">The White Ribbon Project™</a> sent by <a href="/DrewMoghanaki/">Drew Moghanaki 🐕</a> from #WCLC24 

Fiona thanks for all the fabulous work you do for patients with lung cancer🤍🫁

#thewhiteribbonproject
Michael Rynne (@michaelrynne1) 's Twitter Profile Photo

We are one of the wealthiest countries in Europe and have the second highest incidence of cancer, but Ireland only reimbursed 29% of EMA approved cancer drugs compared to 96% in Germany. We are failing cancer patients. Micheál Martin Simon Harris TD

We are one of the wealthiest countries in Europe and have the second highest incidence of cancer, but Ireland only reimbursed 29% of EMA approved cancer drugs  compared to 96% in Germany.
We are failing cancer patients.
 <a href="/MichealMartinTD/">Micheál Martin</a> 
<a href="/SimonHarrisTD/">Simon Harris TD</a>
Roberta Horgan 🇮🇪 (@horganroberta) 's Twitter Profile Photo

Ireland is a pharmaceutical hub developing & exporting cutting-edge cancer drugs. It's shameful to see us so far down the list when it comes to funding of these drugs for our own citizens 😞 we can and must do better. #CancerInequalities

Jill Feldman (@jillfeldman4) 's Twitter Profile Photo

I love my advocate friends ❤️ Advocates aren’t #demure, because progress doesn’t come from staying quiet. We must speak up, stand tall, and push boundaries to provoke change #AdvocateLoudly #MakeCancerLessShitty

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Brilliant perspective on early-stage NSCLC from Dr. Jarushka Naidoo at the LUNGevity Foundation ILCSC conference today. Insightful questions from the audience and Dr. Dr. Amy C. Moore on differences between driver positive and negative NSCLC and the evolving role of ctDNA and other biomarkers.

Brilliant perspective on early-stage NSCLC from Dr. <a href="/DrJNaidoo/">Jarushka Naidoo</a> at the <a href="/LUNGevity/">LUNGevity Foundation</a> ILCSC conference today. Insightful questions from the audience and Dr. <a href="/acmoorephd/">Dr. Amy C. Moore</a> on differences between driver positive and negative NSCLC and the evolving role of ctDNA and other biomarkers.
Roberta Horgan 🇮🇪 (@horganroberta) 's Twitter Profile Photo

If you haven't already had a listen, please do 🙏 . wishes she'd had the information needed to recognise the symptoms of her ovarian cancer earlier. She has a lot of wisdom to share with you for World Gynecologic Oncology Day 💜👇#gynaecancers #WorldGODay2024